Science, Technology & the Future | Peter Fedichev - Quantifying Aging in Large Scale Human Studies (Gero) @scfu | Uploaded August 2019 | Updated October 2024, 3 hours ago.
Gero is a data-driven longevity company that employs physics to reverse engineer biology. Gero's goal is to extend healthy lifespan and delay the onset of chronic age-related diseases.

Peter Fedichev, PhD is Founder & Chief Science Officer of Gero.
A passionate scientist with a background in biophysics, bioinformatics and condensed matter physics, Peter is the driving force behind our team.
He earned his Ph.D. from the University of Amsterdam and conducted research at FOM Institute AMOLF (Netherlands) and the University of Innsbruck.
To date, he has published over 70 papers covering his research on physics, biophysics and aging biology.


Many thanks for watching!

Consider supporting SciFuture by:
a) Subscribing to the SciFuture YouTube channel: youtube.com/subscription_center?add_user=TheRationalFuture

b) Donating
- Bitcoin: 1BxusYmpynJsH4i8681aBuw9ZTxbKoUi22
- Etherium: 0xd46a6e88c4fe179d04464caf42626d0c9cab1c6b
- Patreon: patreon.com/scifuture

c) Sharing the media SciFuture creates: scifuture.org

Kind regards,
Adam Ford
- Science, Technology & the Future